Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 49, Issue 5, 2004, Pages 361-367

  Kriplani, Alka ^a   Agarwal, Nutan ^a,b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

Metformin; Ovary; Polycystic ovary syndrome

Indexed keywords

FOLLITROPIN; GLUCOSE; INSULIN; INSULIN SENSITIZING AGENT; LUTEINIZING HORMONE; METFORMIN; TESTOSTERONE;

ADULT; AMENORRHEA; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; INSULIN; INSULIN RESISTANCE; MENSTRUATION DISTURBANCES; METFORMIN; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; TESTOSTERONE; TREATMENT OUTCOME;

EID: 2442700271     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Franks S: Polycystic ovary syndrome: A changing perspective. Clin Endocrinol 1989;31:87-120
2. Barley CJ, Path MRC, Turner RC: Melformin. N Engl J Med 1996;29:575-579
3. Velazquez ME, Acosta A, Mendoza SG: Menstrual cyclicity after melformin therapy in polycystic ovary syndrome. Obstet Gynecol 1997;90:392-396
4. Iuorno MJ, Nestler JE: Insulin lowering drugs in polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001;28:153-163
5. Zawadzki JK, Dunaif A: Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In Polycystic Ovary Syndrome. Edited by A Dunaif, JR Givens, FP Haseltine. Oxford, Blackwell Scientific, 1992, pp 377-384
6. Hamburg R: Polycystic ovary syndrome from gynaecological curiosity to multi-system endocrinopathy. Hum Reprod 1996;11:29-39
7. Ferriman D, Galley JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447
8. Kolodziezczyk B, Duleba AJ, Spaczynoki RZ, et al: Melformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril 2000;73:1149-1154
9. Tiez NW: Clinical Guide to Laboratory Tests. Third edition. Philadelphia, WB Saunders, 1995, pp 366-367
10. Morin-papunen LC, Koivunen RM, Ruokonen A, et al: Melformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril 1998;69:691-696
11. Moghetti P, Castello R, Negri C, et al: Melformin effects in clinical features, endocrine and metabolic profile and insulin sensitivity in polycystic ovary syndrome: A randomized double blind placebo controlled 6 months trial, followed by open, long term clinical evaluation. J Clin Endicronol Metab 2000;85:139-146
12. Unluhizarci K, Kelestimur F, Bayram F, et al: The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome. Clin Endocrinol 1991;51:231-236
13. Haas DA, Carr BR, Attia GR: Effects of metformin on body mass index, menstrual cyclicity and ovulation induction in women with polycystic ovary syndrome. Fertil Steril 2003;79:469-481
14. Velazquez EM, Mendoza S, Hamer T, et al: Melformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemic and systolic blood pressure, while facilitating normal nausea and pregnancy. Metabolism 1994;43:647-654
15. Crave JC, Fimbel S, Lejeune H, et al: Effects of diet and metformin administration on sex hormone binding globulin, androgens and insulin in hirsute and obese women. J Clin Endocrinol Metab 1995;80:2057-2062
16. Kocak M, Caliskan E, Simsir C, et al: Metformin therapy improves ovulatory rates cervical score and pregnancy rate in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 2002;77:101-106
17. Conn JJ, Jacobs HS: Managing hirsutism in gynaecological practice. Br J Obstet Gynaecol 1998;105:687-696
18. Inzucchi SE, Maggs DG, Spollett GR, et al: Efficacy and metabolic effects of melformin and troglitazone in type II diabetes mellitus. N Engl J Med 1998;338:867-872